Medicare Enrolled
Dr. Thang Le, MD
Rheumatology · Upland, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Thang Le is a rheumatology specialist in Upland, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Le performed 263,000 Medicare services across 2,922 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $7,737 from 33 pharmaceutical and/or device companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$7,737 industry payments
Medicare Practice Summary
Medicare Utilization ↗263,000
Medicare services
Top 1% in CA for rheumatology
2,922
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13,842 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 107,653 | $5 | $8 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
100,800 | $4 | $11 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
14,425 | $34 | $60 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
13,475 | $10 | $27 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
6,665 | $26 | $100 |
| Denosumab injection (Prolia/Xgeva) | 4,741 | $19 | $25 |
| Rituximab biosimilar injection, 10 mg An injection of rituximab-abbs, a biosimilar medication, administered in a 10 mg dose. |
3,500 | $33 | $100 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,547 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
737 | $11 | $35 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
693 | $0 | $15 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
624 | $12 | $50 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
584 | $18 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
563 | $97 | $150 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
561 | $5 | $26 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
559 | $4 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
558 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
558 | $10 | $70 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
557 | $8 | $28 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
514 | $71 | $105 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
488 | $52 | $125 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
390 | $6 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
378 | $22 | $95 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
337 | $29 | $60 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
310 | $1 | $8 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
270 | $3 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
203 | $100 | $215 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
162 | $17 | $25 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
82 | $4 | $25 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
81 | $13 | $25 |
| Immune complex measurement A laboratory test that measures the level of immune complexes in the blood. Immune complexes are formed when antibodies bind to antigens. |
81 | $24 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
75 | $16 | $30 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
74 | $9 | $15 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
74 | $1 | $2 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
73 | $13 | $45 |
| Measurement of dna antibody, single stranded | 73 | $12 | $46 |
| Microsomal antibody test A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system. |
73 | $14 | $25 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
72 | $15 | $25 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
70 | $65 | $145 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
65 | $4 | $30 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
64 | $14 | $25 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
63 | $102 | $150 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
56 | $1 | $10 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $72 | $105 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
25 | $40 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $118 | $185 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.7% high complexity
84.0% medium
2.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,737
Total received (2018-2024)
Avg $1,105/year across 7 years
Top 34% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
485
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,714 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,316
2023
$704
2022
$434
2021
$936
2020
$682
2019
$1,788
2018
$1,877
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$284
GlaxoSmithKline, LLC.
$176
US Oncology Corporate, Inc.
$174
Novartis Pharmaceuticals Corporation
$140
ABBVIE INC.
$131
UCB, Inc.
$115
PFIZER INC.
$92
Fresenius Kabi USA, LLC
$91
ANI Pharmaceuticals, Inc.
$50
Aurinia Pharma U.S., Inc.
$24
DePuy Synthes Sales Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Top 3 companies account for 48.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,133
GlaxoSmithKline, LLC.
$728
E.R. Squibb & Sons, L.L.C.
$696
AbbVie, Inc.
$657
PFIZER INC.
$645
Genentech USA, Inc.
$639
Janssen Biotech, Inc.
$622
Novartis Pharmaceuticals Corporation
$538
ABBVIE INC.
$312
AbbVie Inc.
$223
Horizon Therapeutics plc
$195
UCB, Inc.
$186
US Oncology Corporate, Inc.
$174
Aurinia Pharma U.S., Inc.
$167
GENZYME CORPORATION
$144
Fresenius Kabi USA, LLC
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Mallinckrodt LLC
$71
MEDEXUS PHARMA, INC.
$58
Radius Health, Inc.
$52
ANI Pharmaceuticals, Inc.
$50
DePuy Synthes Sales Inc.
$47
MEDAC PHARMA, INC.
$37
Mallinckrodt Enterprises LLC
$29
Alexion Pharmaceuticals, Inc.
$24
Celgene Corporation
$23
SANOFI-AVENTIS U.S. LLC
$20
Lilly USA, LLC
$19
Organon LLC
$18
Collegium Pharmaceutical, Inc.
$17
Horizon Pharma plc
$15
AstraZeneca Pharmaceuticals LP
$13
Takeda Pharmaceuticals U.S.A., Inc.
$10
Top 3 companies account for 33.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · HUMIRA · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · NEXPLANON · OFEV · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ · XTAMPZA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
68
Per 100K population
3.1
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Le is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Le performed 107,653 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $7,737 from 33 companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other rheumatologists in Upland?
Dr. Le's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Upland
Browse rheumatologists in Upland ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology